Miller-Fisher syndrome with posterior reversible encephalopathy syndrome and stroke that developed as a complication of intravenous immunoglobulin therapy-Reference-Cited by-同舟云学术

Miller-Fisher syndrome with posterior reversible encephalopathy syndrome and stroke that developed as a complication of intravenous immunoglobulin therapy

Published:2018 Issue:1 Volume:40 Page:39-43
ISSN:0912-0726
Container-title:Nosotchu
language:en
Short-container-title:Jpn. J. Stroke

Author:

Imai Takeshi¹,Kato Bunta¹,Ohshima Jun¹,Hasegawa Yasuhiro²

Affiliation:

1. Department of Internal Medicine, Division of Neurology, St. Marianna University School of Medicine, Yokohama City Seibu Hospital

2. Department of Internal Medicine, Division of Neurology, St. Marianna University School of Medicine

Publisher

Japan Stroke Society

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jstroke/40/1/40_10512/_pdf

Reference15 articles.

1. 2) Sato Y, Hirose M, Inoue Y, et al: Reversible posterior leukoencephalopathy syndrome after blood transfusion in a patient with end-stage renal disease. Clin Exp Nephrol 15: 942–947, 2011

2. 4) Overell JR, Hsieh ST, Odaka M, et al: Treatment for Fisher syndrome, Bickerstaff’s brainstem encephalitis and related disorders. Cochrane Database Syst Rev: CD004761, 2007

3. 5) Bartynski WS: Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 29: 1036–1042, 2008

4. 6) Bartynski WS: Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 29: 1043–1049, 2008

5. 7) Stetefeld HR, Lehmann HC, Fink GR, et al: Posterior reversible encephalopathy syndrome and stroke after intravenous immunoglobulin treatment in Miller-Fisher syndrome/Bickerstaff brain stem encephalitis overlap syndrome. J Stroke Cerebrovasc Dis 23: e423–425, 2014